[Sustained reduction in bronchial hyperresponsiveness within three days of inhaled fluticasone propionate in mild asthma:time course after onset and cessation of treatment].
Sovijärvi
Anssi R A
AR
HUSLAB, kliinisen fysiologian ja isotooppilääketieteen laboratoriot, HUS.
Haahtela
Tari
T
Ekroos
Heikki J
HJ
Lindqvist
Ari
A
Saarinen
Antti
A
Poussa
Tuija
T
Laitinen
Lauri A
LA
D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D000730:Androstadienes / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology*; D016535:Bronchial Hyperreactivity / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005387:Finland; D000068298:Fluticasone; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000730:Androstadienes; D000068298:Fluticasone